Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether an uncemented hip prosthesis is as safe as an cemented hip prosthesis for patients undergoing total hip arthroplasty surgery following a displaced femoral neck fracture.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis

NCT02404727

Osteoarthritis, Hip Arthropathy of Hip

COMPLETED NA

Periprosthetic Bone Remodeling Around Uncemented Components in Total Hip Arthroplasty

NCT01319227

Osteoarthritis

UNKNOWN NA

Randomized Controlled Study Comparing a Short Stem Hip Prosthesis With a Stem of Standard Length

NCT02983526

Primary Osteoarthritis of Hip Nos Secondary Osteoarthritis of Hip

COMPLETED NA

Exception Cementless Hip Stem

NCT04349046

Osteoarthritis, Hip Rheumatoid Arthritis Inflammatory Arthritis +3 more

ACTIVE_NOT_RECRUITING

Evaluation of Stability of Two Uncemented Hip Implants Used for Total Hip Arthroplasty

NCT02656771

Osteoarthritis, Hip

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will randomize patients between an uncemented and cemented stem

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cemented femoral stem

Patient undergoing total hip arthroplasty surgery

Group Type ACTIVE_COMPARATOR

Cemented femoral stem

Intervention Type PROCEDURE

All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem

Uncemented femoral stem

Patients undergoing total hip arthroplasty

Group Type ACTIVE_COMPARATOR

Uncemented femoral stem

Intervention Type PROCEDURE

All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Uncemented femoral stem

All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem

Intervention Type PROCEDURE

Cemented femoral stem

All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BiMetric uncemented femoral stem CPT cemented femoral stem

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute Displaced femoral neck fracture
* Subject is aged between 65-79 years
* Independent walker with or without walking aides
* Subject is able and capable of providing consent to participate in the study

Exclusion Criteria

* Patients with Rheumatoid Arthritis
* Patients with an impaired cognitive dysfunction
* Patients with Pathological fractures
* Patients with substance abuse
* Patients with fracture older than 36-hours on arrival at the A\&E
* Patients suffering from cancer
* Patients determined by principal investigator to be unsuitable for inclusion

Minimum Eligible Age

65 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No